Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.
The Dolan Company (NYSE: DM) shares closed down 20.29 percent this past Friday with over 2.2 million shares traded. The stock was one of the biggest decliners on the NYSE and hit a new 52-week low of $0.48 during intra-day trading. The company recently announced that it has appointed Kevin Nystrom, managing director of Zolfo Cooper, as its chief restructuring officer. The Dolan Company is a leading provider of professional services and business information to the legal, financial and real estate sectors.
Get more information on The Dolan Company and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/DM
Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) shares closed down 14.63 percent on Friday with about 7.2 million shares traded. The stock was one of the biggest decliners on the NASDAQ. There was no significant news released by the company to explain the decline but the company was featured in an article on TheStreet that day.
Get more information on Chelsea Therapeutics International Ltd. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/CHTP
Biozone Pharmaceuticals, Inc. (OTCBB: BZNE) shares closed up 7.94 percent on Friday with over 3.1 million shares traded. The stock was one of the biggest gainers in the OTCBB marketplace. The company announced that it has finalized its planned merger with Cocrystal Discovery, Inc., a privately-held, biotechnology company developing antiviral therapeutics for human diseases. Cocrystal Discovery has previously received strategic investments from Teva Pharmaceuticals (TEVA), Opko Health (NYSE MKT: OPK) and The Frost Group.
Get more information on Biozone Pharmaceuticals, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/BZNE
BG Medicine, Inc. (NASDAQ: BGMD) shares closed up 37.74 percent on Friday with about 12.5 million shares almost traded. The stock was one of the biggest gainers on the NASDAQ. There was no significant news released to explain the unusual breakout. BG Medicine, Inc., a diagnostics company, engages in the development and commercialization of novel cardiovascular diagnostic tests to address unmet medical needs in the United States.
Get more information on BG Medicine, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/BGMD
Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.
Leave a comment...